Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-16

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    An Enquiry

    Menu

    Fostemsavir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Rukobia

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Rukobia

    Fostemsavir

    arrow
    APS Symposium
    Not Confirmed

    Brand Name : Rukobia

    United Kingdom
    arrow
    APS Symposium
    Not Confirmed

    GlaxoSmithKline

    Fostemsavir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2020 Revenue in Millions : 15

    2019 Revenue in Millions : 0

    Growth (%) : New Launch

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Rukobia

    Fostemsavir

    arrow
    APS Symposium
    Not Confirmed

    Brand Name : Rukobia

    United Kingdom
    arrow
    APS Symposium
    Not Confirmed

    GlaxoSmithKline

    Fostemsavir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 61

    2020 Revenue in Millions : 15

    Growth (%) : 309

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Rukobia

    Fostemsavir

    arrow
    APS Symposium
    Not Confirmed

    Brand Name : Rukobia

    United Kingdom
    arrow
    APS Symposium
    Not Confirmed

    GSK

    Fostemsavir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2022 Revenue in Millions : 101

    2021 Revenue in Millions : 61

    Growth (%) : 66

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Rukobia

    Fostemsavir

    arrow
    APS Symposium
    Not Confirmed

    Brand Name : Rukobia

    United Kingdom
    arrow
    APS Symposium
    Not Confirmed

    GSK

    Fostemsavir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2023 Revenue in Millions : 126

    2022 Revenue in Millions : 101

    Growth (%) : 43

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Rukobia

    Fostemsavir

    arrow
    APS Symposium
    Not Confirmed

    Brand Name : Rukobia

    United Kingdom
    arrow
    APS Symposium
    Not Confirmed

    GSK

    Fostemsavir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2024 Revenue in Millions : 200

    2023 Revenue in Millions : 126

    Growth (%) : 59

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF